Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cayman
PAD4 (human, recombinant; mammalian expressed)
776
CHF
CHF 776.00
In stock
CAY-32834-5050 µgCHF 776.00
Product Details | |
---|---|
Synonyms | PADI4; PADI5; Peptidylarginine Deiminase 4; Protein Arginine Deiminase Type 4; Protein Arginine Deiminase Type IV |
Product Type | Protein |
Properties | |
Sequence | Recombinant N-terminal His-tagged human PAD4 expressed in HEK293 cells. |
Purity | ≥90% (SDS-PAGE) |
Formulation | 50 mM HEPES, pH 8.0, 300 mM sodium chloride, 1 mM DTT, and 10% glycerol |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Cayman Chemicals. |
Shipping and Handling | |
Shipping | DRY ICE |
Long Term Storage | -80°C |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
Protein arginine deiminase 4 (PAD4) catalyzes the conversion of arginine residues to citrulline within cellular protein substrates, resulting in the loss of a positive charge, which can alter protein structure and/or function. It is expressed in neutrophils, as well as a variety of tissues, including the brain, liver, lung, and kidney. PAD4 has a key role in NETosis, a lytic form of cell death characterized by the release of neutrophil extracellular traps (NETs). Upon neutrophil activation, PAD4 translocates to the nucleus where it citrullinates histones, initiating chromatin decondensation and the release of NETs. Neutrophils isolated from Pad4-/- mice exhibit decreased citrullination of histone H3 under both basal and LPS-stimulated conditions and are defective for NET formation in response to stimulation with LPS.